Zomedica pharmaceuticals corp. (ZOM)
Balance Sheet / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Dec'16
Current assets
Cash and cash equivalents

1,496

510

2,487

5,822

2,296

1,940

526

4,279

3,134

3,448

3,226

Prepaid expenses and deposits

520

1,228

1,497

1,389

1,113

1,867

1,481

1,135

810

786

332

Tax credits and other receivable

142

67

75

95

77

53

37

49

69

28

18

Assets, Current, Total

2,159

1,806

4,061

7,306

3,488

3,860

2,046

5,464

4,015

4,262

3,578

Prepaid expenses, deposits and deferred financing costs

-

-

-

7

47

1,442

1,374

495

518

566

690

Property and equipment

876

729

805

794

859

717

756

444

347

371

289

Right-of-use asset

1,499

1,103

1,231

1,358

1,485

-

-

-

-

-

-

Intangible assets

498

543

513

12

12

13

13

13

14

15

17

Assets, Total

5,034

4,182

6,611

9,479

5,894

6,033

4,190

6,417

4,895

5,215

4,575

Current liabilities
Accounts payable and accrued liabilities

1,578

2,087

1,577

1,796

7,773

2,376

1,280

1,683

1,266

828

734

Current portion of lease obligations

222

-

-

-

-

-

-

-

-

-

-

Shareholder loans payable

-

-

-

-

-

-

-

-

-

-

6

Liabilities, Current, Total

1,801

2,087

1,577

1,796

7,773

2,376

1,280

1,683

1,266

828

741

Lease obligations

1,281

-

-

-

-

-

-

-

-

-

-

Liabilities, Total

3,082

2,087

-

-

-

-

-

-

-

-

-

Shareholders' equity
Balance at March 31, 2020

11,961

11,961

11,961

11,962

-

-

-

-

-

-

-

Unlimited common shares without par value; Issued and outstanding 128,871,732 common shares (2019 - 108,038,398)

39,998

38,566

38,647

38,647

38,643

30,410

25,373

25,258

20,003

18,244

10,189

Common Stock, Value, Subscriptions

-

-

-

-

-

4,280

-

-

-

-

-

Additional paid-in capital

4,500

3,625

3,625

3,427

3,427

1,240

1,388

1,417

1,422

1,768

-

Additional paid-in capital

-

-

-

-

-

-

-

-

-

-

1,205

Accumulated deficit

-54,508

-52,057

-49,200

-46,355

-43,950

-32,273

-23,852

-21,941

-17,797

-15,626

-7,561

Stockholders' Equity Attributable to Parent, Ending Balance

1,951

2,095

5,033

7,682

-1,879

3,657

2,910

4,734

3,629

4,387

3,834

Liabilities and Equity, Total

5,034

4,182

6,611

9,479

5,894

6,033

4,190

6,417

4,895

5,215

4,575